2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
News|Articles|March 15, 2015
- Pharmaceutical Technology-03-15-2015
- Volume 2015 eBook
- Issue 1
Analytical Techniques for Oral Solid Dosage Formulation
Author(s)Paul Kippax, Deborah Huck-Jones
Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients.
Advertisement
Analytical technologies must accurately identify and measure the critical material attributes of APIs and excipients, separately and when combined during oral solid dosage formulation and development.
Download
.
Articles in this issue
over 11 years ago
Advances in Tabletingover 11 years ago
Assessing and Improving the Palatability of Pharmaceuticalsover 11 years ago
Simplify Formulation With PATover 11 years ago
Boosting Solubility in Lipid-Based Formulationsover 11 years ago
Innovations in Solid Dosage EquipmentAdvertisement
Related to this article
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Sanofi will transfer 20 mature medicines and three manufacturing sites to Cheplapharm for a 26.4% equity stake, closing by Q3 2027.
On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
Ask the Expert: Post-Approval Changes
5